SCHEMBL723271

SCHEMBL723271

COc1ccc(-c2cc3nccc(Cl)c3o2)cc1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 2/20 0.50
MAPK1 P28482 5/20 0.46
MAPT P10636 5/20 0.46
ABCB1 P08183 5/20 0.46
ALDH1A1 P00352 4/20 0.46
HSD17B10 Q99714 4/20 0.46
KMT2A Q03164 4/20 0.46
CYP3A4 P08684 3/20 0.46
KDM4E B2RXH2 3/20 0.46
ABCG2 Q9UNQ0 3/20 0.46
MEN1 O00255 3/20 0.46
HPGD P15428 2/20 0.46
CYP1A1 P04798 3/20 0.45
CYP1B1 Q16678 3/20 0.45
CYP1A2 P05177 1/20 0.45
TERT O14746 1/20 0.43
USP2 O75604 1/20 0.43
LMNA P02545 1/20 0.43
ELANE P08246 1/20 0.43
ABCC1 P33527 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL721337 0.91 CYP1A1 (0.44) PDE4AMAPK1MAPTABCB1ALDH1A1
SCHEMBL721335 0.86 SYK (0.45) MAPK1ABCB1ALDH1A1KMT2ACYP3A4
SCHEMBL724620 0.85 PDE4A (0.51) PDE4AMAPK1MAPTABCB1ALDH1A1
SCHEMBL725006 0.83 EGFR (0.46) MAPK1MAPTABCB1ALDH1A1HSD17B10
SCHEMBL15172962 0.83 GAA (0.42) PDE4AMAPK1MAPTALDH1A1HSD17B10
SCHEMBL18339745 0.81 CSNK2A2 (0.39) PDE4AMAPK1MAPTALDH1A1HSD17B10
SCHEMBL721362 0.80 DYRK1A (0.47) MAPK1MAPTALDH1A1HSD17B10KMT2A
SCHEMBL723457 0.80 CYP1A1 (0.36) ABCB1ALDH1A1KMT2ACYP3A4ABCG2
SCHEMBL10267556 0.79 ALDH1A1 (0.44) MAPK1MAPTALDH1A1HSD17B10KMT2A
SCHEMBL721356 0.79 KDM4E (0.42) MAPK1MAPTALDH1A1HSD17B10CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609100-B1 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2015-06-24 EP disclosed
EP-2609100-B1 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2015-06-24 EP disclosed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US disclosed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US disclosed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US disclosed
US-20130225569-A1 FUROPYRIDINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-08-29 US disclosed
US-20130225569-A1 FUROPYRIDINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-08-29 US disclosed
EP-2609100-A2 FUROPYRIDINE DERIVATIVES Merck Patent GmbH (DE) 2013-07-03 EP disclosed
WO-2012025187-A2 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2012-03-01 WO disclosed
WO-2012025187-A2 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2012-03-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130225569-A1 FUROPYRIDINE DERIVATIVES SYK, FCGRT, SSB PDE4A 2125/4885MAPK1 276/4885MAPT 4861/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.